May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Novel Delivery of Laser Therapy With the PASCAL (Pattern Scanning Laser) Photocoagulator
Author Affiliations & Notes
  • A. Gupta
    Ophthalmology/Retina, Jules Stein Eye Institute/UCLA, Los Angeles, California
  • C. R. Gonzales
    Ophthalmology/Retina, Jules Stein Eye Institute/UCLA, Los Angeles, California
  • PASCAL Study Group
    Ophthalmology/Retina, Jules Stein Eye Institute/UCLA, Los Angeles, California
  • Footnotes
    Commercial Relationships A. Gupta, None; C.R. Gonzales, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4028. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Gupta, C. R. Gonzales, PASCAL Study Group; Novel Delivery of Laser Therapy With the PASCAL (Pattern Scanning Laser) Photocoagulator. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4028.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: The PASCAL (Pattern Scanning Laser) photocoagulator delivers a customizable pattern array of laser spots at 532nm wavelength with a much shorter duration per laser application than standard laser delivery systems. Herein we report our initial clinical experience with the PASCAL photocoagulator for a variety of retinal conditions.

Methods:: The PASCAL laser photocoagulator was used to apply laser therapy based upon standard indications for treatment. Indications included high risk diabetic retinopathy, macular edema, and retinal tears. The pulse duration ranged from 10 to 20 milliseconds, and the pattern and size of laser matrix applied varied based on the discretion of the treating physician. Clinical outcomes, patient comfort, duration of treatment, and delivery system utility were evaluated.

Results:: Clinical outcomes mirrored those expected with similar dose and timing of laser treatment for each given indication. Patients reported a higher level of comfort with the PASCAL system compared to other commercially available laser photocoagulation systems. The treating physicians reported increased efficiency, a rapid learning curve, decreased fatigue during treatment, and an overall favorable impression of the PASCAL system.

Conclusions:: The PASCAL laser for retinal photocoagulation may be associated with improved patient and physician satisfaction based on increased efficiency and comfort and potentially improved safety and precision compared with standard single spot laser delivery systems.

Keywords: laser • retina • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×